| Dr Joseph Smolarz, MD | |
|
9149 Estate Thomas Ste 308, St Thomas, VI 00802-3132 | |
| (340) 774-8881 | |
| (340) 776-9807 |
| Full Name | Dr Joseph Smolarz |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 14 Years |
| Location | 9149 Estate Thomas Ste 308, St Thomas, Virgin Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114965373 | NPI | - | NPPES |
| 1072451 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 200496 (Louisiana) | Secondary |
| 174400000X | Specialist | 1634 (Virgin Island) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Roy Lester Schneider Hospital,the | St thomas, VI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Virgin Islands Ear Nose And Throat Pc | 2365521655 | 4 |
News Archive
From low-income countries to high-income countries, long-term exposure to fine particulate outdoor air pollution is a major contributor to cardiovascular disease and death, a new Oregon State University study found.
CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced it has initiated a pivotal global Phase 3 clinical trial to evaluate the efficacy and safety of aldoxorubicin as a second-line treatment for patients with soft tissue sarcoma (STS) under a Special Protocol Assessment with the FDA.
Nexus, a leading provider of advanced technology and network integration, announced the launch of a focused Healthcare Practice. Healthcare is one of the fastest growing industries today and currently generates a large percentage of Nexus' revenue.
The Indian Health Care Improvement Act, the cornerstone legal authority for the provision of health care to American Indians and Alaska Natives, was made permanent when President Obama signed the bill on March 23, as part of the Patient Protection and Affordable Care Act.
› Verified 4 days ago
| Entity Name | Virgin Islands Ear Nose And Throat Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205869260 PECOS PAC ID: 2365521655 Enrollment ID: O20080512000746 |
News Archive
From low-income countries to high-income countries, long-term exposure to fine particulate outdoor air pollution is a major contributor to cardiovascular disease and death, a new Oregon State University study found.
CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced it has initiated a pivotal global Phase 3 clinical trial to evaluate the efficacy and safety of aldoxorubicin as a second-line treatment for patients with soft tissue sarcoma (STS) under a Special Protocol Assessment with the FDA.
Nexus, a leading provider of advanced technology and network integration, announced the launch of a focused Healthcare Practice. Healthcare is one of the fastest growing industries today and currently generates a large percentage of Nexus' revenue.
The Indian Health Care Improvement Act, the cornerstone legal authority for the provision of health care to American Indians and Alaska Natives, was made permanent when President Obama signed the bill on March 23, as part of the Patient Protection and Affordable Care Act.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph Smolarz, MD Po Box 12390, St Thomas, VI 00801-5390 Ph: (340) 774-8881 | Dr Joseph Smolarz, MD 9149 Estate Thomas Ste 308, St Thomas, VI 00802-3132 Ph: (340) 774-8881 |
News Archive
From low-income countries to high-income countries, long-term exposure to fine particulate outdoor air pollution is a major contributor to cardiovascular disease and death, a new Oregon State University study found.
CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced it has initiated a pivotal global Phase 3 clinical trial to evaluate the efficacy and safety of aldoxorubicin as a second-line treatment for patients with soft tissue sarcoma (STS) under a Special Protocol Assessment with the FDA.
Nexus, a leading provider of advanced technology and network integration, announced the launch of a focused Healthcare Practice. Healthcare is one of the fastest growing industries today and currently generates a large percentage of Nexus' revenue.
The Indian Health Care Improvement Act, the cornerstone legal authority for the provision of health care to American Indians and Alaska Natives, was made permanent when President Obama signed the bill on March 23, as part of the Patient Protection and Affordable Care Act.
› Verified 4 days ago